Corbus Pharmaceuticals Announces Topline Results from RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis

Ads

You May Also Like

MDxHealth Reports Fourth Quarter and Fiscal Year 2015 Results

IRVINE, Calif. and HERSTAL, Belgium, Feb. 18, 2016 (GLOBE NEWSWIRE) -- MDxHealth SA (Euronext: ...